chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient fainted 5 minutes after the administration of the vaccine, he could still talk and told me that he was having difficulty breathing so while 911 was on the way I injected one dose of Epinephrine 0.3 mg. He was also pale and sweating.  I was making sure he had a pulse, when 911 arrived they assess him and his blood pressure was a little high.  After maybe 15 minutes he was feeling better and he told us that he was afraid of needles. Honestly we do not know if he was very anxious or if he had a reaction to the injection since he mentioned his throat was closing.
severe headache, duration 72  hours severe nausea and vomiting  requiring antiemetic rx  72 hours diffuse joint pain duration 72 hours diffuse myalgia duration 72 hours
Information has been received from a certified medical assistant (C.M.A.) concerning a 1 year old male foster child and a history of being premature by 3 months and no allergies, who on 20, Dec 2006 was vaccinated subcutaenously with a 0.5 ml dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (+) varicella virus vaccine live (Oka/Merck upgrade process)  (lot# 655314/0978F). Concomitant vaccinations given on the same day included: pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (PREVNAR), rotavirus G1 G2 G4 P1 reassortant vaccine live (human-bovine) (MSD), influenza virus vaccine (unspecified) and diphtheria toxoid (+) pertussis acellular vaccine (unspecified) (+) tetanus toxoid. Eleven days post vaccination. On 01, Jan 2007 the patient developed an outbreak of chickenpox. The child had approximately 15 blisters noted on his forehead and feet/ankles. Unspecified medical attention was sought and no laboratory or diagnostic tests were performed. It was reported that the child had difficulty walking due to the blisters on the feet. No outcome was reported. No product quality complaint was involved. Additional information has been requested
Chest pain, subtle pain in left arm, racing heartbeat started 8-10 after injection and has been persistent since.
occasional twitching on the left eye; she had a pain on the eye in a split of a second; This is a spontaneous report from a contactable healthcare professional via the Medical Information Team. A female patient of an unspecified age started to receive bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration from 30Dec2020 to 30Dec2020 at a single dose for an unspecified indication.  The patient's medical history and concomitant medications were not reported. It was reported that the patient received the first dose of the COVID-19 vaccine on 30Dec2020 and she noticed occasional twitching on the left eye and has been fading away because it has been 10 days now after having her first dose. When she had the COVID-19 vaccine, after a minute or so, she had a pain on the eye in a split of a second. The outcome of the event occasional twitching on the left eye was recovering while unknown for the other event. Information on the lot/batch number has been requested.
Patient hospitalized for sever hyponatremia and tested COVID-19 positive upon admission.  No COVID-19 symptoms, no known exposure.
About 4:00 pm, I started itching all over my body.. I took a Benadryl at 8:30 and went to bed. Spent the night itching all over,  Got up at 6:30 and I had a rash all over my forearms and lower back.  Took another Benadryl and was still itching until about 9:00, but had started to subside. When I got up this morning I had no itching,  but still have rash, but not fire red like the night before. I physically feel a lot better now.
swelling at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (swelling at the injection site) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 10-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-May-2021, the patient experienced VACCINATION SITE SWELLING (swelling at the injection site). At the time of the report, VACCINATION SITE SWELLING (swelling at the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.   Treatment information not reported.   This case was linked to MOD-2021-244799 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Event outcome updated.
This spontaneous report as received from a pharmacist refers to a male patient of unknown age. On an unknown date, the patient was vaccinated with M-M-R II via intradermal route, instead of via the subcutaneous route (dose, lot # and albumin status not provided). Moreover the patient was seeking appointment with the physician to rule out cellulitis due to redness at the injection site (dates not provided). The outcome of the events was unknown. Relatedness between the events and suspect product was not specified. Additional information has been requested.
got sick from my first flu shot; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received the 1st dose of Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   The reporter considered the sickness to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient got sick from first flu shot.
Pt began feeling numbness in fingers, hands and feet. Also a slight irritation of the skin, all symptoms began on Sunday 12/09/2001. Pt saw MD and neurologist 12/11/2001. He phoned today 12/13/2001 to report symptoms and states he feels a slight improvement today from 12/09/2001.
low-grade temperature Fatigue Shortness of breath Wheezing Asthma with acute exacerbation Pneumonia due to COVID-19 virus Chest Pain  prednisone  azithromycin
Information has been received from a medical care administrator concerning her 60 year old mother (physician), with a rheumatoid arthritis with sulfa allergy who on 26-APR-2009 was vaccinated with PNEUMOVAX (dose, route not reported, lot number: 659148/1382U, expiration date: 12-JUN-2009) on the arm. Concomitant therapy included ZOSTAVAX on 25-APR-2009, (dose, route not reported, lot number: 663178/1414X, expiration date: 28-APR-2010) on the other arm, for the treatment of prophylaxis. Other concomitant therapy was stopped "several weeks prior to vaccination" (date unspecified): SYNTHROID and ENBREL. The patient started to feel "crummy and really wretched yesterday" (on 26-APR-2009 and 27-APR-2009). She had redness swelling and erythema at the injection site on the arm that was vaccinated with PNEUMOVAX (unspecified side) also she felt cold, had fevers between 101F to 103F.  On 28-APR-2009, the patient had fever 102.7F and she was taking TYLENOL for the fever. The patient's outcome was not recovered and she sought medical attention, her husband was the physician. Additional information has been requested.
Past the 42 day window/didn't get my second dosage yet; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Past the 42 day window/didn't get my second dosage yet) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Past the 42 day window/didn't get my second dosage yet). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Past the 42 day window/didn't get my second dosage yet) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information were not provided.
vaccine seems to be helping my yeast problem underneath my breast; hard knot 9 days after the vaccine around injection site; little bit itchy; rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INDURATION (hard knot 9 days after the vaccine around injection site), VACCINATION SITE PRURITUS (little bit itchy), VACCINATION SITE RASH (rash around the injection site) and THERAPEUTIC RESPONSE UNEXPECTED (vaccine seems to be helping my yeast problem underneath my breast) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Yeast infection (Yeast problem  underneath my breast). Concomitant products included OLMESARTAN MEDOXOMIL (BENICAR), FUROSEMIDE (LASIX [FUROSEMIDE]), DIAZEPAM, VITAMIN C [ASCORBIC ACID] and PARACETAMOL (TYLENOL) for an unknown indication.    On 29-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Feb-2021, the patient experienced VACCINATION SITE INDURATION (hard knot 9 days after the vaccine around injection site), VACCINATION SITE PRURITUS (little bit itchy) and VACCINATION SITE RASH (rash around the injection site). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (vaccine seems to be helping my yeast problem underneath my breast). At the time of the report, VACCINATION SITE INDURATION (hard knot 9 days after the vaccine around injection site), VACCINATION SITE PRURITUS (little bit itchy) and VACCINATION SITE RASH (rash around the injection site) outcome was unknown and THERAPEUTIC RESPONSE UNEXPECTED (vaccine seems to be helping my yeast problem underneath my breast) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment reported was rubbing alcohol for little bit itchy event.
GI symptoms; This non-serious case was reported by a nurse via sales rep and described the occurrence of gastrointestinal upset in an unspecified number of patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced gastrointestinal upset (Verbatim: GI symptoms). The outcome of the gastrointestinal upset was not reported.   It was unknown if the reporter considered the gastrointestinal upset to be related to Shingrix.     It was unknown if the company considered the gastrointestinal upset to be related to Shingrix.   Additional Information: GSK receipt date: 16-MAR-2023 The health care professional (HCP) stated that in general patients stated that they experience Gastrointestinal upset (GI) symptoms after 2nd dose. The reporter did not agree to follow up from GSK.
Began feeling delirious around 7:00pm - uneasy and strange. Upon walking to the subway station, I felt overwhelmed with sudden depressive thoughts and anxiety.   On the Subway, I had a very severe, and disturbing panic attack. My vision became blurred and distorted, my heart rate spiked, and I became nauseous and extremely frightened. I sat down to try to maintain a sense of calm - but got off the subway after a few stops and met with a friend whom I had texted, to take care of me. From the point on, I was very shaken and agitated, and have been since the event.    I have never experienced anxiety, depression, or any such symptoms in my life before, nor was I nervous or anxious about having received the vaccine. The onset of the event was sudden, and seemingly out of nowhere, without real purpose, hence my conviction that it may have been spurred as a side effect from the vaccination.  I went to Urgent Care Sunday morning, April 11th, the morning after the event. My resting pulse was 97 BPM (normally 52-54) - and my blood pressure much higher than normal - 175/110. The doctor insisted I go home "and relax".    I still feel uneasy and shaken from the event.
Pt. has red area at site of injection. The area streaked out larger than the size of his band-aid.
This spontaneous report was received from a pharmacist, and refers to a patient of unknown age and gender. The patient's medical history and concurrent conditions were not reported. No concomitant medication information was provided. On an unknown date, the patient started therapy with methotrexate (manufacturer unknown) tablets, per oral, for an unknown indication (dose, frequency, lot number and expiration date were not reported). While on therapy with methotrexate (manufacturer unknown), the patient was vaccinated with a dose of ZOSTAVAX for prophylaxis (dose, route of administration, lot number and expiration date were not reported). No adverse effects were reported. No product quality complaint was involved. Additional information has been requested.
This spontaneous report as received from a healthcare worker (medical assistant, M.A.) refers to a patient of unknown age and gender. Pertinent medical history and drug reactions or allergies were not specified. On 29-MAY-2014, an unspecified patient was vaccinated with a dose of PROQUAD (dose number, dose, frequency, route and lot number were not specified), 1 vial, which was exposed to temperature ranges outside of product information (PI) (exact temperatures and dates not specified). Concomitant medications were not specified. No adverse effects were reported. No product quality complaint (PQC) was reported. This is one of several reports received from the same reporter. Additional information has been requested.
4-20-12 1100 pt returned to office stating left arm swollen, seen by dr who advised pt to go to urgent care. Pt states was given IV fluids and antibiotics Trimethoprim and Cephalexin was re-examined 4-22-12. Swelling diminished/slight discomfort (per patient).
1 of 2 pts vaxed from the same lots exp urticarial rash following vax w/Tetramune/OPV; pt recovered;
The patient fainted briefly for few seconds upon administering the flu vaccine.  Pulse and breathing within normal limits, patient sweat a little.  Patient was coherent and conscious, EMS was called just in case, but not use service due to non life threatening.
Itching, under neck swollen, chills, extreme weakness, fatgue, ABD cramping, rapid heart beat, head aches, and no appetite. Patient went to the ED that morning and was given Atarax for itching. No swelling observed my medical staff. Only thing objective on exam was excoriations. There was no indication to be admitted to the hospital at that time. She also went to outside ED who gave her something for itching as well, was not admitted.
Seven days after the vaccine, my skin became itchy and then red. This has continued to todays date and will sporadically occur during the day and may wake me up during the night. I have been self medicating with benadryl  topical and sometimes the tablets. I am concerned because I am supposed to receive my 2nd dose 03/04/2021
Patient presented to clinic with two invalid doses of DTaP on record (only four valid doses). Patient was given Kinrix after nurse counted only the valid doses. Dose counted but per orders should have received a waiver for this 7th dose of DTaP. Patient symptoms unreported at this point.
26JAN93 mom reports pt is normally a very good; fussy, crying both time immun given; t100 R, site was swollen size of orange; 8PM cried/sobbed; fussy x 5 days; site was so tender & sore;
Developed scratchy throat and then itchy rash at approximately 15 minutes post dose.  Patient given 50 mg oral Benadryl and monitored for over 30 minutes.  Patient has a history of epi pen usage due to history of allergies to sulfa, flaxseed and environmental triggers.  She has received flu vaccine in the past with minimal reactions. Given oral benadryl 50mg x 1 and monitored for at least an additional 30 minutes.  Per pt on my chart in March: tingling of the tongue was mild. The right ear and right side of my head was intense with pressure and it did feel like it wanted to explode. After the Benadryl it started to subside. It lasted about 50 minutes. The rash were not like hives. The rash was on my neck , arms and face. It lasted about 2 days and was a mild case. Not over body. No fainting, no low grade fever.
Gave me frequent headaches. My wife diagnosed me with a different attitude after the shots. I get mad most of the time with no apparent reason. I suddenly have frequent colds and fever from 100.4 to 101.5.
pt recvd vax & w/in 15-30mins pt exp SOB,weakness,dizziness,& passed out;addl exp tingling over body,stomach cramps,nausea;pt was monitored in MD office & all sx resolved;no further details;
Information has been received from a health professional concerning a 5 year old male who was vaccinated with a dose of varicella virus vaccine live. Subsequently the patient developed mild breakthrough varicella. Unspecified medical attention was sought and the patient's breakthrough was confirmed. The patient's outcome was unknown. The patient was not hospitalized. There was no product quality complaint involved. Additional information has been requested.
Information has been received from a physician concerning a 7-year-old male with no known allergies or pertinent medical history who on 05-APR-2007 was vaccinated in his left arm with a 0.5 ml (25U) first dose of VAQTA (lot# 656017/1280F). There were no illnesses reported at the time of vaccination. There was no concomitant medication. On 07-APR-2007 (previously reported as 10-APR-2007) the patient's left arm was swollen and red at the injection site. Medical attention was sought. The area was reported to be 10 cm x 5 cm. The patient was treated with ice packs and BENADRYL. No lab tests were performed. On 12-APR-2007 the patient recovered from the adverse events. There was no product quality complaint involved. No further information was provided. The physician requested a lot check of the vaccine, a lot check has been requested. The records of testing prior to release of the lot in question have been rechecked and found to be satisfactory. The lot met the requirements of the government and was released by the regulatory agency. Additional information is not expected. This is one of several reports from the same source.
Patient was given the Moderna vaccine in error, because she is only 15 years of age. Patient has not experienced any symptoms or adverse reaction outside of the normal pain at the injection point and upper arm area.
First complaint was neck arm stiffness of left side, which continued, confustion (goofy like she was drunk), conti complaints of neck arm, then exhaustion just wanted to sleep out of no where, then extreme headache migraine past 10 in pain, crying holding head, light/sound sensitivity... then could not breathe, starting paniacing can't breathe , cant breathe my chest ..911 called, became hot sweaty, dizzy, neauseous, somewhat incoherent, emt had to ask questions 3 or 4 times to get answer, brought to hospital, had apnea issues 3X ( had nurse give her oxygen) while waiting for Dr. She was hydrated and given raglan after symptoms subsided sent home after midnight. Stayed home the next day, headaches, light/noise sensitivity continued, attempted to go to work 5/12 at 5pm had to be brought home 2.5 hours later, attempted school 5/13 headache, fatigued, exhaustion, back ache, leg pain helped 2 nurses office by 2 friends, called at 10:30am picked up at 11:17 bourght to car in wheel chair... 5/13 brought to dr's office for continued symptoms. Tried to say it could be other things. My child hardly gets sick, was fine not even a sniffle before vaccinations were administered. She is on bed rest with continued symptoms until 5/15.  5/14/09 ED records received DOS 5/11/09. FINAL DIAGNOSIS: Adverse reaction to Menactra vaccine Complained of neck pain and headache, then chills, tingling in arm, dizziness, symptoms exacerbated by light and noise. Confusion.  LABS and DIAGNOSTICS: CBC - WNL, CHEM - WNL, CT Head - WNL.  5/15/09 medical records received (also contains copy of ED records for 5/11/09) DOS 5/11/09 to 5/13/09. FINAL DIAGNOSIS: Possible Menactra reaction Fever, chills, headache, sore throat with erythema, decreased appetite, and fatigue persist post ED visit on 5/11/09.
Information was received on 10-JAN-2017 from a nurse regarding an male patient (age not reported). Medical history/concurrent conditions included hypertension, degenerative joint disease, arthritis and hearing loss.  Concomitant medications included aspirin, amlodipine, omega-3 acid ethyl esters (LOVAZA) and losartan potassium (+) hydrochlorothiazide (HYZAAR). No allergies were reported. On 18-MAR-2016 the patient was administered ZOSTAVAX (lot # M000555 expiration date 27-MAR-2017). On 29-DEC-2016 the patient came to the office with shingles to the right upper leg and groin area and right hip and back which started on 25-DEC-2016. Shingles was not resolved and the patient continued to be treated. The nurse did not rate the causal relationship. No further information was provided. The nurse asked to have the VZV packet to be faxed. Additional information has been requested.
Swelling; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING (Swelling) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 prophylaxis.    Co-suspect product included non-company product HYALURONIC ACID (RESTYLANE) for an unknown indication.    No Medical History information was reported.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form and HYALURONIC ACID (RESTYLANE) (unknown route) at an unspecified dose. On an unknown date, the patient experienced SWELLING (Swelling). At the time of the report, SWELLING (Swelling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The concomitant medication was not reported by reporter. It was reported that patient was out until the 17th. Also, a patient did Restylane under eyes. Patient got Moderna recently and had swelling and patient wanted to hyaluronidase. The treatment medication was not reported by reporter.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 23-JUN-2015 the patient was vaccinated with ROTATEQ (dose was not reported, route of vaccination defaulted to oral, lot # K013661 with expiration date: 26-MAY-2016), which was improperly stored. No adverse symptoms reported. This is one of several reports from the same reporter. Additional information has been requested.
Went to ER crying uncontrollably, breath holding episode, went rigid, wouldn't feed. Occurred within hours of 1st vaccinations.
10/13/20/ pm - Received FLU vaccine. About 3pm facial itching, lips tingling, throat itching/tight feeling. 5:30 pm took Allegra which resolved symptoms.
Pt was admitted to hospital 12/25/09. Office was informed 12/29/09. Dx of GUILLIAN-BARRE Syndrome. Pt hospitalized 12/25/09 with 10 day hx of progressive ascending weakness.